Self-reported exposure to neurotoxic chemical combinations in the Gulf War: A cross-sectional epidemiologic study

JAMA

Volumn 277, Issue 3, 1997, Pages 231-237

  Haley, Robert W ^a   Kurt, Thomas L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL WARFARE AGENT; CHOLINESTERASE; DIETHYLTOLUAMIDE; NEUROTOXIC ESTERASE; NEUROTOXIN; PYRIDOSTIGMINE;

ADULT; ARTHROPATHY; ARTICLE; ATAXIA; COGNITIVE DEFECT; CONFUSION; FACTORIAL ANALYSIS; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MYOPATHY; NEUROPATHY; NEUROTOXICITY; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; SELF REPORT;

EID: 0031030843     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.3.231     Document Type: Article

References (69)

1. Defense Science Board. Report of the Defense Science Board Task Force on Persian Gulf War Health Effects. Washington, DC: Office of the Under Secretary of Defense for Acquisition and Technology; 1994.
2. NIH Technology Assessment Workshop Panel. The Persian Gulf experience and health. JAMA. 1994;272:391-396.
3. Committee on Banking, Housing and Urban Affairs, US Senate. US Chemical and Biological Warfare-Related Dual Use Exports to Iraq and Their Possible Impact on the Health Consequences of the Persian Gulf War. Washington, DC: US Senate; 1994.
4. Committee to Review the Health Consequences of Service During the Persian Gulf War, Medical Follow-up Agency, Institute of Medicine. Health Consequences of Service during the Persian Gulf War: Initial Findings and Recommendations for Immediate Action. Washington, DC: National Academy Press; 1995.
5. Johnson MK. Organophosphorus and other inhibitors of brain 'neurotoxic esterase' and the development of delayed neurotoxicity in hens. Biochem J. 1970;120:523-531.
6. Sabri MI, Spencer PS. Toxic distal axonopathy. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore, Md: Williams & Wilkins; 1980:206-219.
7. Johnson MK. Receptor or enzyme: the puzzle of NTE and organophosphate-induced delayed polyneuropathy. Trends Pharmacol Sci. 1987;8:174-179.
8. Abou-Donia MB, Lapadula DM. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Annu Rev Pharmacol Toxicol. 1990;30:405-440.
9. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit Rev Toxicol. 1991;21:465-487.
10. Richardson R. Interactions of organophosphorus compounds with neurotoxic esterase. In: Chambers J, Levi P, eds. Organophosphates. San Diego, Calif: Academic Press; 1992:299-323.
11. Hayes WJ Jr, Laws ER Jr, eds. Handbook of Pesticide Toxicology. New York, NY: Academic Press Inc; 1991.
12. Ecobichon DJ. Organophosphorus ester insecticides. In: Ecobichon DJ, Joy RM, eds. Pesticides and Neurological Diseases. 2nd ed. Boston, Mass: CRC Press Inc; 1994:171-250.
13. Goldberg J, Eisen SA, True WR, Henderson WG. Health effects of military service. Ann Epidemiol. 1992;2:841-853.
14. Lees-Haley PR, Brown RS. Biases in perception and reporting following a perceived toxic exposure. Percept Mot Skills. 1992;75:531-544.
15. Taubes G. Epidemiology faces its limits. Science. 1995;269:164-169.
16. Haley RW, Kurt TM, Hom J. Is there a Gulf War syndrome? searching for syndromes by factor analysis of symptoms. JAMA. 1997;277:215-222.
17. Abou-Donia MB, Wilmarth KR, Jensen KF, Oehme FW, Kurt TL. Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin. J Toxicol Environ Health. 1996;48:35-56.
18. Abou-Donia MB, Wilmarth KR, Abdel-Rahman AA, Jensen KF, Oehme FW, Kurt TL. Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol. 1996:34;201-222.
19. Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA. 1991;266:693-695.
20. Cook JE, Kolka MA. Chronic pyridostigmine bromide administration. Mil Med. 1992;157:250-254.
21. Wenger CB, Quigley MD, Kolka MA. Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat. Aviat Space Environ Med. 1993;64:905-911.
22. Sharabi Y, Danon Y, Berkenstadt H, et al. Survey of symptoms following intake of pyridostigmine during the Persian Gulf War. Isr J Med Sci. 1991;27:656-658.
23. Cattell RB. The Scientific Use of Factor Analysis in Behavioral and Life Sciences. New York, NY: Plenum Press; 1978.
24. Rummel RJ. Applied Factor Analysis. Evanston, Ill: Northwestern University Press; 1970.
25. SAS/STAT User's Guide: Version 6. 4th ed. Cary, NC: SAS Institute Inc; 1990.
26. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1989.
27. Kleinbaum DG, Kupper LL, Morgenstern H. Statistical inferences about effect measures: simple analysis, section 15.1: hypothesis-testing procedures. In: Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982:284-295.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
29. Snedecor GW, Cochran WG. Statistical Methods. Ames: Iowa State University Press; 1980.
30. Kleinbaum DG, Kupper LL, Morgenstern H. Interaction, effect modification, and synergism. In: Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982:403-418.
31. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol. 1976:103:506-511.
32. Hogan DH, Kupper LL, Most BM, Haseman JK. Alternatives to Rothman's approach for assessing synergism (or antagonism) in cohort studies. Am J Epidemiol. 1978;108:60-67.
33. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariable Methods. 2nd ed. Boston, Mass: PWS-KENT Publishing Company; 1988.
34. De Bleecker JL, De Reuck JL, Willems JL. Neurological aspects of organophosphate poisoning. Clin Neurol Neurosurg. 1992;94:93-103.
35. Bouldin TW, Cavanagh JB. Organophosphorus neuropathy, I. Am J Pathol. 1979;94:241-252.
36. Smith MI, Elvove E, Frazier WH. The pharmacological action of certain phenol esters with special reference to the etiology of so-called ginger paralysis (second report). Public Health Rep. 1930; 45:2509-2524.
37. Morgan JP, Penovich P. Jamaica ginger paralysis. Arch Neurol. 1978;35:530-532.
38. Petty CS. Organic phosphate insecticide poisoning. Am J Med. 1958;24:467-470.
39. Savage EP, Keefe TJ, Mounce LM, Heaton RK, Lewis JA, Burcar PJ. Chronic neurologic sequelae of acute organophosphate pesticide poisoning. Arch Environ Health. 1988;43:38-45.
40. Rosenstock L, Keifer M, Daniell WE, McConnell R, Claypoole K, and the Pesticide Health Effects Study Group. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet. 1991;338:223-227.
41. Kaplan JG, Kessler J, Rosenberg N, Schaumburg HH. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology. 1993;43: 2193-2196.
42. Haley RW, Hom J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans: a blinded case-control study. JAMA. 1997;277:223-230.
43. Jamal GA, Hansen S, Apartopoulos F, Peden A. Is there neurological dysfunction in 'Gulf War syndrome'? J Neurol Neurosurg Psychiatry. 1996;60: 449-451.
44. Doctor BP, Blick DW, Caranto G, et al. Cholinesterases as scavengers for Organophosphorus compounds. Chem Biol Interact. 1993;87:285-293.
45. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against Organophosphorus poisoning in nonhuman primates. J Pharm Exp Ther. 1991;259:633-638.
46. La Du BN. Human serum paraoxonase/arylesterase. In: Kalow W, ed. Pharmacogenetics of Drug Metabolism. New York, NY: Pergamon Press Inc; 1992:51-91.
47. Dunn MA, Sidell FR. Progress in medical defense against nerve agents. JAMA. 1989;262:649-652.
48. Dirnhuber P, Green DM. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman. J Pharm Pharmacol. 1978;30: 419-425.
49. Koplovitz I, Harris LW, Anderson DR, Lennox WJ, Stewart JR. Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents. Fundam Appl Toxicol. 1992;18:102-106.
50. Satz P. Brain reserve capacity on symptom onset after brain injury. Neuropsychology. 1993;7: 273-295.
51. Pope CN, Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol Environ Health. 1990;31:261-273.
52. Osimitz TG, Grothaus RH. The present safety assessment of DEET. J Am Mosquito Control Assoc. 1995;11:274-278.
53. Robbins PJ, Cherniack MG. Review of the bio-distribution and toxicity of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health. 1986;18:503-525.
54. Idson B. Percutaneous absorption. J Pharm Sci. 1975;64:901-924.
55. Windheuser JJ, Haslan JL, Caldwell L, Shaffer RD. The use of N,N-diethyl-m-toluamide to enhance dermal and transdermal delivery of drugs. J Pharm Sci. 1982;71:1211.
56. Micromedia Healthcare Services. POISINDEX, CD-ROM Version. Englewood, Calif: Micromedex Inc; 1995.
57. Capodicasa E, Scapellato ML, Moretto A, Caroldi S, Lotti M. Chlorpyrifos-induced delayed polyneuropathy. Arch Toxicol. 1991;65:150-155.
58. Mount ME, Moller G, Cook J, Holstege DM, Richardson ER, Ardans A. Clinical illness associated with a commercial tick and flea product in dogs and cats. Vet Hum Toxicol. 1991;33:19-27.
59. Miller SA, Blick DW, Kerenyi SZ, Murphy MR. Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacol Biochem Behav. 1993;44:343-347.
60. Gordon JJ, Inns RH, Johnson MK, et al. The delayed neuropathic effects of nerve agents and some other organophosphorus compounds. Arch Toxicol. 1983;52:71-82.
61. Willems JL, Nicaise M, De Bisschop HC. Delayed neuropathy by the organophosphorus nerve agents soman and tabun. Arch Toxicol. 1984;55:76-77.
62. Sidell FR, Borak J. Chemical warfare agents, II: nerve agents. Ann Emery Med. 1992;21:865-871.
63. Husain K, Vijayaraghavan R, Pant SC, Raza SK, Pandey KS. Delayed neurotoxic effect of sarin in mice after repeated inhalation exposure. J Appl Toxicol. 1993;13:143-145.
64. Husain K, Pant SC, Raza SK, Singh R, Das Gupta S. A comparative study of delayed neurotoxicity in hens following repeated administration of organophosphorus compounds. Indian J Physiol Pharmacol. 1995;39:47-50.
65. Spiegelberg U. Psychopathologisch-neurologische Schaden nach Einwirkung synthetischer Gifte. In: Wehrdienst und Gesundheit, Vol III. Darmstadt, Germany: Wehr und Wissen Verlagsgesellschaft mbH; 1961.
66. Stockholm International Peace Research Institute. Delayed Toxic Effects of Chemical Warfare Agents: A Stockholm International Peace Research Institute Monograph. New York, NY: Almquist and Wiskell International; 1975.
67. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol. 1974;7:1-17.
68. Duffy FH, Burchfiel JL, Bartels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol. 1979;47:161-176.
69. Baker DB, Greenland S, Mendlein J, Harmon P. A health study of two communities near the String-fellow waste disposal Site. Arch Environ Health. 1988;43:325-334